{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T22:51:20Z","timestamp":1781563880367,"version":"3.54.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"publisher","award":["HIPS\/19\/27"],"award-info":[{"award-number":["HIPS\/19\/27"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"DOI":"10.1186\/s40814-025-01681-x","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T09:01:24Z","timestamp":1753866084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A protocol for a pilot randomised controlled trial of a Tailored Intervention for people with moderate-to-severe Chronic Obstructive Pulmonary Disease and Co-morbidities delivered by Pharmacists and Consultant respiratory Physicians (TICC-PCP) in Scotland"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6440-9089","authenticated-orcid":false,"given":"Richard","family":"Lowrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Moir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Attwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Rankine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Greenlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Owusu","family":"Achiaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances S.","family":"Mair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"1681_CR1","unstructured":"Global strategy for prevention, diagnosis and management of COPD: 2024 report. 2024 GOLD Report - Global Initiative for Chronic Obstructive Lung Disease - GOLD (goldcopd.org)"},{"key":"1681_CR2","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1016\/j.chest.2020.12.055","volume":"159","author":"Y Fu","year":"2021","unstructured":"Fu Y, Mason A, Boland AC, et al. Palliative care needs and integration of palliative care support in COPD: a qualitative study. Chest. 2021;159:2222\u201332.","journal-title":"Chest"},{"key":"1681_CR3","doi-asserted-by":"publisher","unstructured":"Sullivan J et al. National and State estimates of COPD morbidity and mortality\u2014United States 2014\u20132015. Chronic Obstr Pulm Dis 2018. Oct 12;5(4):324\u2013333. https:\/\/doi.org\/10.15326\/jcopdf.5.4.2018.0157","DOI":"10.15326\/jcopdf.5.4.2018.0157"},{"key":"1681_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.pupt.2018.06.004","volume":"51","author":"U Vespasiani-Gentilucci","year":"2018","unstructured":"Vespasiani-Gentilucci U, Pedone C, Muley-Vilamu M, et al. The pharmacological treatment of chronic co-morbidities in COPD: mind the gap! Pulm Pharmacol Ther. 2018;51:48\u201358.","journal-title":"Pulm Pharmacol Ther"},{"key":"1681_CR5","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"JR Hurst","year":"2010","unstructured":"Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128\u201338.","journal-title":"N Engl J Med"},{"key":"1681_CR6","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1164\/rccm.200912-1843CC","volume":"182","author":"MK Han","year":"2010","unstructured":"Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010;182:598\u2013604.","journal-title":"Am J Respir Crit Care Med"},{"key":"1681_CR7","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1056\/NEJMoa1105482","volume":"365","author":"J Vestbo","year":"2011","unstructured":"Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011;365:1184\u201392.","journal-title":"N Engl J Med"},{"key":"1681_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1183\/09059180.00004014","volume":"23","author":"F Patalano","year":"2014","unstructured":"Patalano F, Banerji D, D\u2019Andrea P, et al. Addressing unmet needs in the treatment of COPD. Eur Respir Rev. 2014;23:333\u201344. https:\/\/doi.org\/10.1183\/09059180.00004014.","journal-title":"Eur Respir Rev"},{"key":"1681_CR9","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1183\/09031936.00118912","volume":"41","author":"M Miravitlles","year":"2013","unstructured":"Miravitlles M, Soler-Catalu\u00f1a JJ, Calle M, et al. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur Respir J. 2013;41:1252\u20136.","journal-title":"Eur Respir J"},{"key":"1681_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037483","volume":"7","author":"A Agust\u0131","year":"2012","unstructured":"Agust\u0131 A, Edwards LD, Rennard SI, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS ONE. 2012;7: e37483.","journal-title":"PLoS ONE"},{"key":"1681_CR11","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1136\/thorax.55.12.1000","volume":"55","author":"JM Gore","year":"2000","unstructured":"Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000;55:1000\u20136.","journal-title":"Thorax"},{"key":"1681_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.pec.2007.05.011","volume":"68","author":"JM Habraken","year":"2007","unstructured":"Habraken JM, Willems DL, De Kort SJ, Bindels PJE. Health care needs in end-stage COPD: A structured literature review. Patient Educ Couns. 2007;68:121\u201330.","journal-title":"Patient Educ Couns"},{"key":"1681_CR13","first-page":"989","volume":"106","author":"A Corrado","year":"2012","unstructured":"Corrado A, Rossi A. How far is real life from COPD therapy guidelines? An Italian observational study Respir Med. 2012;106:989\u201397.","journal-title":"An Italian observational study Respir Med"},{"issue":"Suppl. 56","key":"1681_CR14","first-page":"524s","volume":"40","author":"M Small","year":"2012","unstructured":"Small M, Broomfield S, Higgins V. Quantification and treatment patterns of real-world patients classified by the GOLD 2011 strategy. Eur Respir J. 2012;40(Suppl. 56):524s.","journal-title":"Eur Respir J"},{"key":"1681_CR15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/ajrccm.164.3.2004029","volume":"164","author":"DB Coultas","year":"2001","unstructured":"Coultas DB, Mapel D, Gagnon R, et al. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med. 2001;164:372\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"1681_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/BF00433917","volume":"5","author":"AJ Crockett","year":"1996","unstructured":"Crockett AJ, Cranston JM, Moss JR, Alpers JH. The MOS SF-36 health survey questionnaire in severe chronic airflow limitation: comparison with the Nottingham health profile. Qual Life Res. 1996;5:330\u20138.","journal-title":"Qual Life Res"},{"key":"1681_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1471-2466-14-102","volume":"14","author":"J Koskela","year":"2014","unstructured":"Koskela J, Kilpel\u00e4inen M, Kupiainen H, et al. Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD. BMC Pulm Med. 2014;14:102. https:\/\/doi.org\/10.1186\/1471-2466-14-102.","journal-title":"BMC Pulm Med"},{"issue":"14","key":"1681_CR18","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","volume":"360","author":"SF Jencks","year":"2009","unstructured":"Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360(14):1418\u201328.","journal-title":"N Engl J Med"},{"issue":"1","key":"1681_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3109\/15412555.2014.922065","volume":"12","author":"DS Mowls","year":"2015","unstructured":"Mowls DS, Cheruvu VK, Schilz R, Zullo MD. COPD in a nationally representative sample: sociodemographic factors and co-morbidity, diagnosis method, and healthcare utilization. COPD. 2015;12(1):96\u2013103.","journal-title":"COPD"},{"issue":"1","key":"1681_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12890-020-1136-8","volume":"20","author":"T Goto","year":"2020","unstructured":"Goto T, Yoshida K, Faridi MK, Camargo CA Jr, Hasegawa K. Contribution of social factors to readmissions within 30 days after hospitalization for COPD exacerbation. BMC Pulm Med. 2020;20(1):107.","journal-title":"BMC Pulm Med"},{"issue":"10","key":"1681_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046433","volume":"7","author":"U Nurmatov","year":"2010","unstructured":"Nurmatov U, Buckingham S, Kendall M, et al. Effectiveness of holistic interventions for people with severe chronic obstructive pulmonary disease: systematic review of controlled clinical trials Plos One. 2010;7(10): e46433. https:\/\/doi.org\/10.1371\/journal.pone.0046433.","journal-title":"Effectiveness of holistic interventions for people with severe chronic obstructive pulmonary disease: systematic review of controlled clinical trials Plos One"},{"key":"1681_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/COPD.S54473","volume":"10","author":"G Hillas","year":"2015","unstructured":"Hillas G, Perlikos F, Tsiligianni I, Tzanakis N. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:95\u2013109. https:\/\/doi.org\/10.2147\/COPD.S54473.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"128","key":"1681_CR23","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1378\/chest.128.4.2017","volume":"4","author":"D Coultas","year":"2005","unstructured":"Coultas D, Jenn F, Bethany B, et al. A randomised trial of two types of nurse-assisted home care for patients with COPD. Chest. 2005;4(128):2017\u201324. https:\/\/doi.org\/10.1378\/chest.128.4.2017.","journal-title":"Chest"},{"key":"1681_CR24","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/bmj.325.7370.938","volume":"325","author":"O Hermiz","year":"2002","unstructured":"Hermiz O, Comino E, Marks G, et al. Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease. BMJ. 2002;325:938.","journal-title":"BMJ"},{"key":"1681_CR25","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(97)11048-0","volume":"351","author":"JH Gravil","year":"1998","unstructured":"Gravil JH, Al-Rawas OA, Cotton MM, Flanigan U, Irwin A, Stevenson RD. Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service. Lancet. 1998;351:1853\u20135.","journal-title":"Lancet"},{"key":"1681_CR26","doi-asserted-by":"crossref","unstructured":"Strijbos JH,Postma DS,van Altena R,Gimeno F,Koeter GH.A comparison between an outpatient hospital based pulmonary rehabilitation program and a home care pulmonary rehabilitation program in patients with COPD: a follow-up of 18 months. Chest 1996;109:366\u201372.","DOI":"10.1378\/chest.109.2.366"},{"key":"1681_CR27","unstructured":"Kaffash J. GPs vote for home visits to be removed from contract. Pulse 2019; 22 Nov: http:\/\/www.pulsetoday.co.uk\/news\/gps-vote-for-home-visits-to-beremoved-from-contract\/20039743.article (accessed 28 Apr 2020)"},{"key":"1681_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/2042098616646726","volume":"7","author":"LC Cope","year":"2016","unstructured":"Cope LC, Abuzour AS, Tully MP. Nonmedical prescribing: where are we now? Ther Adv Drug Saf. 2016;7:165\u201372.","journal-title":"Ther Adv Drug Saf"},{"key":"1681_CR29","unstructured":"Department of Health. Pharmacist Independent Prescribing FAQ: Department of Health (2010) http:\/\/webarchive.nationalarchives.gov.uk\/+\/www.dh.gov.uk\/en\/Healthcare\/Medicinespharmacyandindustry\/Prescriptions\/TheNon-MedicalPrescribingProgramme\/Independentpharmacistprescribing\/DH_4133943"},{"key":"1681_CR30","doi-asserted-by":"crossref","unstructured":"Lowrie, R., McPherson, A., Mair, FS et al. Holistic health and social care outreach for people experiencing homelessness with recent non-fatal overdose in Glasgow, Scotland: the Pharmacist and third sector Homeless charity worker Outreach Engagement Non-medical Independent prescriber Rx (PHOENIx) pilot randomised controlled trial. BMJ Public Health 2024 2: p. e000219-e000219. https:\/\/bmjpublichealth.bmj.com\/content\/2\/1\/e000219","DOI":"10.1136\/bmjph-2023-000219"},{"key":"1681_CR31","doi-asserted-by":"publisher","unstructured":"Hunt V, Anderson D, Lowrie R, Montgomery Sardar C, Ballantyne S, Bryson G, Kyle J, Hanlon P. A non-randomised controlled pilot study of clinical pharmacist collaborative intervention for community dwelling patients with COPD. npj Primary Care Respiratory Medicine 2018;28:38. https:\/\/doi.org\/10.1038\/s41533-018-0105-7","DOI":"10.1038\/s41533-018-0105-7"},{"key":"1681_CR32","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1016\/j.sapharm.2021.07.015","volume":"18","author":"H Foot","year":"2022","unstructured":"Foot H, Scott I, Sturman N, et al. Impact of pharmacist and physician collaborations in primary care on reducing readmission to hospital: a systematic review and meta-analysis. Res Social Adm Pharm. 2022;18:2922\u201343.","journal-title":"Res Social Adm Pharm"},{"key":"1681_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2061","author":"K Skivington","year":"2021","unstructured":"Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021. https:\/\/doi.org\/10.1136\/bmj.n2061.","journal-title":"BMJ"},{"key":"1681_CR34","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1007\/s11096-014-0024-9","volume":"36","author":"H Zhong","year":"2014","unstructured":"Zhong H, Ni XJ, Cui M, et al. Evaluation of pharmacist care for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Clin Pharm. 2014;36:1230\u201340. https:\/\/doi.org\/10.1007\/s11096-014-0024-9.","journal-title":"Int J Clin Pharm"},{"key":"1681_CR35","doi-asserted-by":"publisher","unstructured":"Abrams R., Br J Gen Pract 2020; https:\/\/doi.org\/10.3399\/bjgp20X710153","DOI":"10.3399\/bjgp20X710153"},{"key":"1681_CR36","doi-asserted-by":"crossref","unstructured":"Bestall JC , PaulEA, GarrodR, GarnhamR, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54758158610377201","DOI":"10.1136\/thx.54.7.581"},{"key":"1681_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1687","volume":"348","author":"TC Hoffmann","year":"2014","unstructured":"Hoffmann TC, Glasziou PP, Boutron I, Milne R, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348: g1687. https:\/\/doi.org\/10.1136\/bmj.g1687.","journal-title":"BMJ"},{"key":"1681_CR38","unstructured":"Taskforce on Medicines Partnership, The National Collaborative Medicines Management Services programme. Room for review\u2014a guide to medicatio review: the agenda for patients, practitioners and managers. 2002."},{"key":"1681_CR39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11136-016-1397-0","volume":"26","author":"DT Eton","year":"2017","unstructured":"Eton DT, Yost KJ, Lai JS, et al. Development and validation of the patient experience with treatment and self-management (PETS): a patient-reported measure of treatment burden. Qual Life Res. 2017;26:489\u2013503.","journal-title":"Qual Life Res"},{"issue":"10","key":"1681_CR40","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011Dec;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"3","key":"1681_CR41","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones PW, Harding G, Berry P. Development and first validation of the COPD assessment test. Eur Respir J. 2009Sep;34(3):648\u201354.","journal-title":"Eur Respir J"},{"issue":"6","key":"1681_CR42","first-page":"613","volume":"50","author":"K Kroenke","year":"2009","unstructured":"Kroenke K, Spitzer RL, Williams JB, Low B. An ulra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50(6):613\u201321.>","journal-title":"Psychosomatics"},{"issue":"2","key":"1681_CR43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j..2002.384.doc.x","volume":"10","author":"GA Lancaster","year":"2004","unstructured":"Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good clinical practice. J Eval Clini Pract. 2004;10(2):307\u201312.","journal-title":"J Eval Clini Pract"},{"key":"1681_CR44","unstructured":"Scottish health service costs - Costs Book 2020 (April 2019 to March 2020) - Scottish health service costs - Publications - Public Health Scotland. Accessed June 28, 2024. https:\/\/publichealthscotland.scot\/publications\/scottish-health-service-costs\/scottish-health-service-costs-costs-book-2020-april-2019-to-march-2020\/"},{"key":"1681_CR45","unstructured":"Personal Social Services Research Unit and the Centre for Health Economics. Unit costs of health and social care programme. 2022. University of York and University of Kent."},{"key":"1681_CR46","unstructured":"https:\/\/publichealthscotland.scot\/publications\/scottish-health-service-costs\/scottish-health-service-costs-costs-book-2020-april-2019-to-march-2020\/"},{"key":"1681_CR47","unstructured":"https:\/\/www.nice.org.uk\/about\/what-we-do\/our-programmes\/nice-guidance\/technology-appraisal-guidance\/eq-5d-5l"},{"key":"1681_CR48","doi-asserted-by":"crossref","unstructured":"Van Hout B, Janssen MF, Feng YS et al. Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets. Value in Health 2012; 15(5):708\u2013715. https:\/\/www.valueinhealthjournal.com\/article\/S1098-3015(12)00058-7\/fulltext?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1098301512000587%3Fshowall%3Dtrue","DOI":"10.1016\/j.jval.2012.02.008"},{"issue":"3","key":"1681_CR49","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1177\/0038038509103208","volume":"43","author":"C May","year":"2009","unstructured":"May C, Finch T. Implementing, embedding, and integrating practices: an outline of Normalization Process Theory. Sociology. 2009;43(3):535\u201354.","journal-title":"Sociology"},{"key":"1681_CR50","doi-asserted-by":"crossref","unstructured":"May C, Cummings A, Girling M et al. Using normalisation process theory in feasibility studies and process evaluations of complex healthcare interventions: a systematic review. Implementation Science 2018;80 (13).","DOI":"10.1186\/s13012-018-0758-1"},{"issue":"6","key":"1681_CR51","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3122\/jabfm.2021.06.210191","volume":"34","author":"EA Rogers","year":"2021","unstructured":"Rogers EA, Abi H, Linzer M, Eton DT. Treatment burden in people with hypertension is correlated with patient experience with self-management. J Am Board Fam Med. 2021;34(6):1243\u20135.","journal-title":"J Am Board Fam Med"},{"key":"1681_CR52","doi-asserted-by":"crossref","unstructured":"Lee MK, St Sauver JL, Anderson RT, Linzer M, Eton DT. Confirmatory factor analyses and differential item functioning of the patient experience with treatment and self-management (PETS vs. 2.0): a measure of treatment burden. Patient Relat Outcome Meas. 2020;11:249\u201363.","DOI":"10.2147\/PROM.S282728"},{"key":"1681_CR53","doi-asserted-by":"crossref","unstructured":"Eton D, Egginton J, Ridgeway J, Odell L, May C, Montori VM. Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study. Patient Relat Outcome Meas 2012;3:39\u201349.47.","DOI":"10.2147\/PROM.S34681"},{"key":"1681_CR54","unstructured":"https:\/\/www.heraldscotland.com\/news\/national\/uk-today\/23156157.royal-mail-strikes-december-2021-postal-strikes\/"},{"issue":"3","key":"1681_CR55","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.hrtlng.2021.02.003","volume":"50","author":"OK Nordfonn","year":"2021","unstructured":"Nordfonn OK, Morken IM, Bru LE, Larsen AI, Huseb\u00f8 AML. Burden of treatment in patients with chronic heart failure\u2014A cross-sectional study. Heart Lung. 2021;50(3):369\u201374.","journal-title":"Heart Lung"},{"key":"1681_CR56","doi-asserted-by":"publisher","unstructured":"Ibrahim K, Cox NJ, Stevenson JM, Lim S et al. A systematic review of the evidence for deprescribing interventions among older people living with frailty. BMC Geriatrics 2021; 21 (258): https:\/\/doi.org\/10.1186\/s12877-021-02208-8","DOI":"10.1186\/s12877-021-02208-8"},{"key":"1681_CR57","doi-asserted-by":"crossref","unstructured":"Omuya H, Nickel C, Wilson P et al. A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy. Int J Pharm Pract. 2023; 30;31(4):349\u2013368. https:\/\/pubmed.ncbi.nlm.nih.gov\/37155330\/","DOI":"10.1093\/ijpp\/riad025"},{"key":"1681_CR58","first-page":"689","volume":"17","author":"GA Traver","year":"1998","unstructured":"Traver GA. Measures of symptoms of life quality to predict emergent use of institutional health care resources in COPD. Heart Lung. 1998;17:689\u201397.","journal-title":"Heart Lung"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-025-01681-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40814-025-01681-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-025-01681-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T07:28:20Z","timestamp":1757316500000},"score":1,"resource":{"primary":{"URL":"https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-025-01681-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1681"],"URL":"https:\/\/doi.org\/10.1186\/s40814-025-01681-x","relation":{},"ISSN":["2055-5784"],"issn-type":[{"value":"2055-5784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approved by the South East Scotland Research Ethics Committee 01. REC reference: 20\/SS\/0093, September 2020.\u00a0Trial sponsor: NHS Greater Glasgow and Clyde","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided written informed consent for publishing.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}